United States · FDA National Drug Code directory
Prazosin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-666_441dd676-fc13-c6ce-e063-6294a90a82a7
- Product NDC
- 10135-666
- Form
- CAPSULE
- Composition / generic term
- Prazosin Hydrochloride
- Labeler
- Marlex Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181001
- Source listing expiry
- 20271231
Source-listed ingredients
- PRAZOSIN HYDROCHLORIDE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (10135-666-01) · 10135-666-01
- 1000 CAPSULE in 1 BOTTLE (10135-666-10) · 10135-666-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →